hydrocortisone-17-butyrate has been researched along with hydrocortisone acetate in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (46.15) | 18.7374 |
| 1990's | 2 (15.38) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 2 (15.38) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Jurs, PC; Stouch, TR | 1 |
| Bodor, N; Harget, AJ; Phillips, EW | 1 |
| Solo, AJ; Suto, MJ; Szeto, DW; Tramposch, KM | 1 |
| Abellán Guillén, A; Cordeiro, MN; Garrido Escudero, A; Morales Helguera, A; Pérez-Garrido, A | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Kejda, J | 1 |
| Crijns, MB; Nater, JP; van der Valk, PG; van Oostveen, F | 1 |
| Giannetti, A; Laria, G; Seidenari, S | 1 |
| el-Azhary, RA; Fransway, AF; Gibson, LE; Lutz, ME | 1 |
| Miścicka, M; Sadlej-Sosnowska, N; Wilczyńska-Wojtulewicz, I | 1 |
| Bieber, T; Bos, JD; Cambazard, F; Fabbri, P; Fölster-Holst, R; Groenhoej Larsen, C; Ortonne, JP; Reitamo, S; Sand, C; Vena, G | 1 |
| Gunnarsson, L; Jensen, LB; Magnussson, E; Nielsen, HM; Petersson, K; Vermehren, C | 1 |
| Juppo, M; Mäkelä, MJ; Pelkonen, AS; Perälä, M; Remitz, A; Salava, A | 1 |
4 trial(s) available for hydrocortisone-17-butyrate and hydrocortisone acetate
| Article | Year |
|---|---|
[Hydrocortisone 17-butyrate and hydrocortisone acetate. Comparison in chronic eczema].
Topics: Adult; Aged; Chronic Disease; Clinical Trials as Topic; Double-Blind Method; Eczema; Female; Humans; Hydrocortisone; Male; Middle Aged; Ointments | 1984 |
Vasoconstrictor and the anti-inflammatory effects of 7 corticosteroids.
Topics: Acute Disease; Adrenal Cortex Hormones; Adult; Betamethasone; Betamethasone Valerate; Clobetasol; Dermatitis, Contact; Female; Humans; Hydrocortisone; Male; Middle Aged; Patch Tests; Skin; Triamcinolone Acetonide; Vasoconstriction | 1984 |
[Hydrocortisone-17-butyrate (0.1 percent) versus hydrocortisone acetate (1 percent) in atopic dermatitis. Controlled double-blind study of 20 children].
Topics: Administration, Topical; Adolescent; Anti-Inflammatory Agents; Child; Child, Preschool; Clinical Trials as Topic; Dermatitis, Atopic; Dermatologic Agents; Double-Blind Method; Female; Humans; Hydrocortisone; Infant; Male | 1981 |
A multicentre, randomized, double-blind, controlled study of long-term treatment with 0.1% tacrolimus ointment in adults with moderate to severe atopic dermatitis.
Topics: Adult; Chi-Square Distribution; Dermatitis, Atopic; Dermatitis, Irritant; Double-Blind Method; Drug Administration Schedule; Female; Glucocorticoids; Herpes Simplex; Humans; Hydrocortisone; Immunosuppressive Agents; Male; Ointments; Sample Size; Statistics, Nonparametric; Tacrolimus; Time Factors; Treatment Outcome | 2005 |
9 other study(ies) available for hydrocortisone-17-butyrate and hydrocortisone acetate
| Article | Year |
|---|---|
Computer-aided studies of the structure-activity relationships between the structure of some steroids and their antiinflammatory activity.
Topics: Anti-Inflammatory Agents; Humans; Numerical Analysis, Computer-Assisted; Steroids; Structure-Activity Relationship; Vasoconstriction | 1986 |
Structure-activity relationships in the antiinflammatory steroids: a pattern-recognition approach.
Topics: Animals; Anti-Inflammatory Agents; Drug Synergism; Granuloma; Humans; Models, Chemical; Rats; Steroids; Structure-Activity Relationship; Vasoconstriction | 1983 |
Relative affinity of 17 alpha- and/or 21-esters and 17 alpha, 21-diesters of cortisol for a glucocorticoid receptor from rat thymocytes.
Topics: Animals; Binding, Competitive; Chemical Phenomena; Chemistry; Cytosol; Esters; Hydrocortisone; Male; Rats; Rats, Inbred Strains; Receptors, Glucocorticoid; Receptors, Steroid; Structure-Activity Relationship; Thymus Gland | 1982 |
Convenient QSAR model for predicting the complexation of structurally diverse compounds with beta-cyclodextrins.
Topics: beta-Cyclodextrins; Hydrophobic and Hydrophilic Interactions; Organic Chemicals; Quantitative Structure-Activity Relationship | 2009 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Contact hypersensitivity to tixocortol pivalate.
Topics: Administration, Topical; Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Allergens; Anti-Allergic Agents; Anti-Bacterial Agents; Anti-Inflammatory Agents; Budesonide; Cross Reactions; Dermatitis, Allergic Contact; Europe; Facial Dermatoses; Female; Humans; Hydrocortisone; Male; Middle Aged; Minnesota; Neomycin; Patch Tests; Prevalence; Risk Factors; Triamcinolone | 1998 |
[Extraction of components from hydrocortisone mixtures using high pressure thin layer chromatography ].
Topics: Aerosols; Chlorquinaldol; Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Hydrocortisone; Ointments; Oxytetracycline | 1990 |
Corticosteroid solubility and lipid polarity control release from solid lipid nanoparticles.
Topics: Adrenal Cortex Hormones; Betamethasone Valerate; Biological Availability; Delayed-Action Preparations; Diglycerides; Hydrocortisone; Hydrophobic and Hydrophilic Interactions; Lipids; Nanoparticles; Palmitates; Particle Size; Solubility; Triglycerides; Viscosity | 2010 |
Effective treatment of atopic dermatitis in small children significantly improves the quality of life of patients and their families.
Topics: Administration, Topical; Dermatitis, Atopic; Dermatologic Agents; Family; Female; Follow-Up Studies; Humans; Hydrocortisone; Immunosuppressive Agents; Infant; Longitudinal Studies; Male; Ointments; Pruritus; Quality of Life; Severity of Illness Index; Tacrolimus | 2021 |